Rapid screening and sensitive detection of NPM 1 (nucleophosmin) exon 12 mutations in acute myeloid leukaemia

被引:20
作者
Scholl, S.
Muegge, L.-O.
Landt, O.
Loncarevic, I. F.
Kunert, C.
Clement, J. H.
Hoeffken, K.
机构
[1] Univ Jena, Dept Internal Med Oncol & Haematol 2, D-6900 Jena, Germany
[2] TIB Molbiol, Berlin, Germany
[3] Univ Jena, Inst Human Genet, D-6900 Jena, Germany
关键词
NPM; 1; mutation; real-time PCR; MRD; LightCycler;
D O I
10.1016/j.leukres.2006.12.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nucleophosmin mutations of exon 12 (NPM1 mutations) represent the most frequent molecular aberration that can be found in patients with acute myeloid leukaemia (AML) and can be detected in about 35% of AML patients. NPM1 mutations are characterised by four basepair insertions within the region corresponding to the C-terminus of the protein leading to its translocation out of the nucleus. Until now, more than 40 different subsets of mutations have been identified and about 90% of NPM1 mutations are represented by subtype A and B (78% versus 12%, respectively). So far, standard screening of NPM1 mutations using conventional polymerase chain reaction (PCR) followed by capillary electrophoresis is rather time consuming. We established a new method for rapid screening of NPM1 mutations using the fluorescence resonance energy transfer (FRET) principle. Furthermore, based on individual NPM1 mutations type A and B, we designed mutation specific primers to perform a highly sensitive PCR assay that can be applied for the detection of minimal residual disease (MRD). In summary, we demonstrate new methodological approaches for rapid screening of NPM1 mutations as well as for MRD analyses based on the most frequent NPM1 mutations. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1205 / 1211
页数:7
相关论文
共 22 条
[1]   Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance [J].
Alcalay, M ;
Tiacci, E ;
Bergomas, R ;
Bigerna, B ;
Venturini, E ;
Minardi, SP ;
Meani, N ;
Diverio, D ;
Bernard, L ;
Tizzoni, L ;
Volorio, S ;
Luzi, L ;
Colombo, E ;
Lo Coco, F ;
Mecucci, C ;
Falini, B ;
Pelicci, PG .
BLOOD, 2005, 106 (03) :899-902
[2]   Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype [J].
Boissel, N ;
Renneville, A ;
Biggio, V ;
Philippe, N ;
Thomas, X ;
Cayuela, JM ;
Terre, C ;
Tigaud, I ;
Castaigne, S ;
Raffoux, E ;
De Botton, S ;
Fenaux, P ;
Dombret, H ;
Preudhomme, C .
BLOOD, 2005, 106 (10) :3618-3620
[3]   Determination of minimal residual disease in leukaemia patients [J].
Campana, D .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (06) :823-838
[4]   Nucleophosmin mutations in De novo acute myeloid leukemia:: The age-dependent incidences and the stability during disease [J].
Chou, WC ;
Tang, JL ;
Lin, LI ;
Yao, M ;
Tsay, W ;
Chen, CY ;
Wu, SJ ;
Huang, CF ;
Chiou, RJ ;
Tseng, MH ;
Lin, DT ;
Lin, KH ;
Chen, YC ;
Tien, HF .
CANCER RESEARCH, 2006, 66 (06) :3310-3316
[5]  
den Besten W, 2005, CELL CYCLE, V4, P1593
[6]   Rapid genotyping of the OATP1B1 polymorphisms A388G and T521C with real-time PCR FRET assays [J].
den Buijsch, RAMO ;
Bekers, O ;
Wijnen, PAHM ;
van Dieijen-Visser, MP ;
de Vries, JE .
PHARMACOGENOMICS, 2005, 6 (04) :393-397
[7]   Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:: interaction with other gene mutations [J].
Döhner, K ;
Schlenk, RF ;
Habdank, M ;
Scholl, C ;
Rücker, FG ;
Corbacioglu, A ;
Bullinger, L ;
Fröhling, S ;
Döhner, H .
BLOOD, 2005, 106 (12) :3740-3746
[8]   Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. [J].
Falini, B ;
Mecucci, C ;
Tiacci, E ;
Alcalay, M ;
Rosati, R ;
Pasqualucci, L ;
La Starza, R ;
Diverio, D ;
Colombo, E ;
Santucci, A ;
Bigerna, B ;
Pacini, R ;
Pucciarini, A ;
Liso, A ;
Vignetti, M ;
Fazi, P ;
Meani, N ;
Pettirossi, V ;
Saglio, G ;
Mandelli, F ;
Lo-Coco, F ;
Pelicci, P ;
Martelli, MF .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :254-266
[9]  
Falini B, 2006, BLOOD
[10]   Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML [J].
Falini, Brunangelo ;
Bolli, Niccolò ;
Shan, Jing ;
Martelli, Maria Paola ;
Liso, Arcangelo ;
Pucciarini, Alessandra ;
Bigerna, Barbara ;
Pasqualucci, Laura ;
Mannucci, Roberta ;
Rosati, Roberto ;
Gorello, Paolo ;
Diverio, Daniela ;
Roti, Giovanni ;
Tiacci, Enrico ;
Cazzaniça, Giovanni ;
Biondi, Andrea ;
Schnittger, Suzanne ;
Haferlach, Torsten ;
Hiddemann, Wolfgang ;
Martelli, Massimo F. ;
Gu, Wei ;
Mecucci, Cristina ;
Nicoletti, Ildo .
BLOOD, 2006, 107 (11) :4514-4523